Platform-Based Mild Cognitive Impairment (MCI) Trial

Platform-based Mild Cognitive Impairment (MCI) Trial

The process of receiving a diagnosis of mild cognitive impairment (MCI) is recognized to induce behavioral responses that can be either adaptive or maladaptive. Five specific areas of concern have been identified, including: 1) failure to plan for future decline, decreased compliance and interaction with medical care providers, 3) decreased confidence and reduced social engagement, 4) increased physical limitations and 5) decreased medication compliance. In this pilot study, participants with MCI and their study partners will participate in behavioral interventions (primarily training workshops and classes) targeting each of these five areas of potential maladaptive behaviors.

No pharmaceutical medication involved
Patients and healthy individuals accepted

Behavioral - Planning for the Future

This intervention will include attending an advance directives meeting, a living arrangements workshop, and a psychosocial education training workshop.

Behavioral - Enhanced Medical Engagement

This intervention includes creating a health portfolio, health record access training, and a medical engagement workshop

Behavioral - Confidence Building and Social Engagement

This intervention includes mindfulness training, a pre-experience training techniques workshop and a memory strategies class.

Behavioral - Physical Intervention

This intervention includes physical/occupational therapy (PT/OT), a home safety assessment, and an independent exercise program.

Behavioral - Medical Adherence

This intervention includes using automated pillboxes to ensure medication compliance, optimizing appropriate medication use through review, and engaging with memory medications via class.

Platform-Based Mild Cognitive Impairment (MCI) Trial to Address Maladaptive Behaviors